VERTEX ORAL ANTI-INFLAMMATORY DRUG R&D PROGRAM WILL RECEIVE UP TO $30 MIL.

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".